Back to Pacer Advisors, Inc. Pacer Advisors, Inc.

TEVATEVA

Showing 8 of 26 quarters

Position history for Pacer Advisors, Inc.Pacer Advisors, Inc.'s holdings in TEVA PHARMACEUTICAL INDS LTD

Yes. Pacer Advisors holds 8,811 shares of TEVA (Teva Pharmaceutical Industries), worth $299,000, as of its Q2 2026 13F filing. It reduced the position by 440 shares (-4.8%) from Q1 2026. Pacer Advisors has held TEVA since Q4 2022, across 15 quarterly 13F filings.

Current Value

$299,000

Current Shares

8,811

Total Value Change

+$125,179

Total Shares Change

-835

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
8,811
-4.8%
$299,0000.0%$33.88
0
2026-Q1
Increased
9,251
+2.9%
$279,0000.0%$30.12
24
2025-Q4
Decreased
8,987
-3.4%
$280,4840.0%$31.21
0
2025-Q3
Decreased
9,301
-5.7%
$187,8800.0%$20.20
0
2025-Q2
Decreased
9,864
-4.6%
$165,3210.0%$16.76
0
2025-Q1
Increased
10,339
+3.0%
$158,9100.0%$15.37
23
2024-Q4
Increased
10,042
+4.1%
$221,3260.0%$22.04
24
2024-Q3
Decreased
9,646
-0.8%
$173,8210.0%$18.02
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used